UASt regulatory sequences drive expression of an inverted repeat.
Expression under the control of Scer\GAL41407 may result in loss of neuroblasts in the larval brain associated with decreased size of the remaining neuroblasts (depending on the insertion line used).
Expression under the control of Scer\GAL41407 results in shorter neuroblast lineages (less daughter cells per neuroblast) in the larval brain compared to controls.
Expression under the control of Scer\GAL41407 may result in an increase in the average size of ganglion mother cells in the larval brain compared to controls (depending on the insertion line used).
Expression under the control of Scer\GAL41407 may result in mild defects in the shape of neuroblasts in the larval brain (depending on the insertion line used).
Adults expressing CG4554GD10709 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Expression of CG4554GD10709 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) results in viable flies or complete lethality, depending on the particular P{GD10709} insertion line used.
Depending on the insertion line used, expression under the control of Scer\GAL4Mef2.PR can result in early larval lethality or late larval lethality.
Expression under the control of Scer\GAL4Mef2.PR results in split larval body wall muscles.
Expression under the control of Scer\GAL4Mef2.PR results in sarcomeres with reduced Z-lines in the larval body wall muscles.
Expression under the control of Scer\GAL4pnr-MD237 may result in semi-lethality, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in bristle morphology defects on the notum in 0% or 10-20% of the Scer\GAL4pnr-MD237 expression domain, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 80-90% or 90-100% of the Scer\GAL4pnr-MD237-expressing area of the notum, depending on the insertion line used.